Ravi Rao

494 total citations
8 papers, 336 citations indexed

About

Ravi Rao is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Ravi Rao has authored 8 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Ravi Rao's work include Rheumatoid Arthritis Research and Therapies (4 papers), Fixed Point Theorems Analysis (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Ravi Rao is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Fixed Point Theorems Analysis (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Ravi Rao collaborates with scholars based in United Kingdom, United States and Canada. Ravi Rao's co-authors include Clifton O. Bingham, Daniel E. Furst, Paul Emery, Ariella Kelman, Marianne T. Sweetser, Ronald van Vollenhoven, Edward Keystone, Roy Fleischmann, Katherine Macey and Benjamin Hsu and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology and RMD Open.

In The Last Decade

Ravi Rao

8 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ravi Rao United Kingdom	5	184	109	102	75	66	8	336
Gema Bonilla Spain	8	255 1.4×	112 1.0×	56 0.5×	92 1.2×	58 0.9×	20	384
X. Mariette France	2	195 1.1×	68 0.6×	61 0.6×	28 0.4×	83 1.3×	3	374
E. Becerra Spain	9	80 0.4×	112 1.0×	80 0.8×	52 0.7×	48 0.7×	25	300
Nicola Tyson United Kingdom	5	131 0.7×	136 1.2×	160 1.6×	37 0.5×	65 1.0×	6	376
Ann Igoe United States	6	162 0.9×	110 1.0×	33 0.3×	28 0.4×	70 1.1×	7	307
E Röther Germany	10	130 0.7×	113 1.0×	50 0.5×	93 1.2×	45 0.7×	23	288
Michela Ferro Italy	10	109 0.6×	46 0.4×	44 0.4×	106 1.4×	64 1.0×	31	316
Sheila Kelly United States	11	400 2.2×	220 2.0×	61 0.6×	26 0.3×	155 2.3×	17	553
Ayanbola Elegbe United States	8	308 1.7×	116 1.1×	104 1.0×	16 0.2×	142 2.2×	22	424
Hjalmar Wadström Sweden	6	230 1.3×	81 0.7×	88 0.9×	17 0.2×	56 0.8×	9	340

Countries citing papers authored by Ravi Rao

Since Specialization

Citations

This map shows the geographic impact of Ravi Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Rao more than expected).

Fields of papers citing papers by Ravi Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Rao. The network helps show where Ravi Rao may publish in the future.

Co-authorship network of co-authors of Ravi Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Rao. A scholar is included among the top collaborators of Ravi Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Rao. Ravi Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Aletaha, Daniel, Clifton O. Bingham, George Karpouzas, et al.. (2021). Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE). RMD Open. 7(1). e001465–e001465. 14 indexed citations

2.

Schmidt, Wolfgang, Bhaskar Dasgupta, Raashid Luqmani, et al.. (2020). A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis. Rheumatology and Therapy. 7(4). 793–810. 36 indexed citations

3.

Taylor, Peter C., Michael Schiff, Qingmin Wang, et al.. (2018). Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study. Annals of the Rheumatic Diseases. 77(5). 658–666. 19 indexed citations

4.

Takeuchi, Tsutomu, Carter Thorne, George Karpouzas, et al.. (2017). Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study. Annals of the Rheumatic Diseases. 76(12). 2001–2008. 55 indexed citations

5.

Rao, Ravi, et al.. (2013). A common fixed point theorem on fuzzy metric space. Kathmandu University Journal of Science Engineering and Technology. 8(2). 77–82. 2 indexed citations

6.

Rao, Ravi, et al.. (2012). A Focus on a Common Fixed Point Theorem using Weakly Compatible Mappings. Mathematical theory and modeling. 2(3). 60–65. 2 indexed citations

7.

Rao, Ravi, et al.. (2012). Design and Analysis of Steam Turbine Blades using FEM. 2(2). 67–73. 1 indexed citations

8.

Vollenhoven, Ronald van, Paul Emery, Clifton O. Bingham, et al.. (2010). Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials. The Journal of Rheumatology. 37(3). 558–567. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact